Study of the Pharmacokinetics and Safety of Dioxidine®, Solution for Topical and External Use, 0.25 mg/ml, in Various Routes of Administration
Topical use of antibacterial drugs as part of complex therapy for purulent-inflammatory infections of the skin and oropharynx can not only eliminate the symptoms but also influence the cause of the disease. Dioxidine® is a broad-spectrum antibacterial drug, active against both gram-positive and gram...
Saved in:
Main Authors: | V. A. Stepanov, S. V. Ponasenkova, E. S. Simonova, P. D. Sobolev, A. G. Nikiforova, A. A. Globenko, A. V. Kapashin, M. A. Pasko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2024-03-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/1096 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of The Toxicological Profile of The New Dioxidine Dosage Form (Solution for Topical and External Use, 0.025%)
by: M. V. ZHURAVLEVA, et al.
Published: (2022-11-01) -
Dioxidin: Antimicrobial Activity and Prospects of Its Clinical Use at Present
by: D. A. Popov, et al.
Published: (2020-05-01) -
Study of the effect of food on the bioavailability, safety and tolerability of Aterixen<sup>®</sup> 100 mg tablet in healthy volunteers
by: V. B. Vasilyuk, et al.
Published: (2023-07-01) -
POTENTIONALS OF TOPIC TREATMENT OF TONSILLOPHARYNGITIS IN CHILDREN IN LOCAL PEDIATRICIANS PRACTICE
by: T. M. Tchernova, et al.
Published: (2012-02-01) -
Pyoderma gangrenosum: update and guidance
by: Luiz Felipe Duarte Fernandes Vieira, et al.
Published: (2022-12-01)